Combination glecaprevir, pibrentasvir with ezetimibe prevents HCV in transplantation - Healio

6/24/2022 12:00:00 AM2 years 10 months ago

LONDON — Combined glecaprevir and pibrentasvir with ezetimibe prevented hepatitis C infection among patients who received non-liver solid organ transplants with HCV viremic grafts, according to research.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.Back to Healio LONDON — Combined glecaprevir and pibren… [+2591 chars]

full article...

Combination glecaprevir, pibrentasvir with ezetimibe prevents HCV in transplantation - Healio

LONDON &mdash; Combined glecaprevir and pibrentasvir with ezetimibe prevented hepatitis C infection among patients who received non-liver solid organ transplants with HCV viremic grafts, according to research.

LONDON — Combined glecaprevir and pibrentasvir with ezetimibe prevented hepatitis C infection among patients who received non-liver solid organ transplants with HCV viremic grafts, according to research.